Viewing Study NCT06476535


Ignite Creation Date: 2025-12-24 @ 10:29 PM
Ignite Modification Date: 2026-01-05 @ 6:12 PM
Study NCT ID: NCT06476535
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-26
First Post: 2024-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy
Sponsor: University Hospital, Brest
Organization:

Study Overview

Official Title: Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OPIUM
Brief Summary: The study will collect cases of MPN patients who also benefit from an anti-inflammatory immunotherapy for another disease. Efficacy and tolerability of the drug will be assessed in this population.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: